Cassava Financial Statements From 2010 to 2024

SAVA Stock  USD 3.84  0.14  3.52%   
Cassava Sciences financial statements provide useful quarterly and yearly information to potential Cassava Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cassava Sciences financial statements helps investors assess Cassava Sciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cassava Sciences' valuation are summarized below:
Gross Profit
-68 M
Market Capitalization
191.5 M
Earnings Share
(1.38)
We have found one hundred twenty available fundamental signals for Cassava Sciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cassava Sciences prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 892 M. The current year's Enterprise Value is expected to grow to about 777.5 M

Cassava Sciences Total Revenue

(1,800)

Check Cassava Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cassava Sciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 4.6 M or Total Revenue of 0.0, as well as many indicators such as Dividend Yield of 0.24, Ptb Ratio of 7.21 or Days Sales Outstanding of 145. Cassava financial statements analysis is a perfect complement when working with Cassava Sciences Valuation or Volatility modules.
  
Check out the analysis of Cassava Sciences Correlation against competitors.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

Cassava Sciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets114.4 M151.7 M81.6 M
Slightly volatile
Total Current Liabilities7.4 M14.2 MM
Pretty Stable
Total Stockholder Equity80.1 M137.5 M69.7 M
Slightly volatile
Property Plant And Equipment Net22.9 M21.9 MM
Slightly volatile
Accounts Payable11.1 M10.6 M2.7 M
Slightly volatile
Cash69.6 M121.1 M70.1 M
Slightly volatile
Non Current Assets Total23.1 M22 M6.2 M
Slightly volatile
Cash And Short Term Investments100.9 M121.1 M73.8 M
Slightly volatile
Net Receivables1.1 M1.1 M914.4 K
Slightly volatile
Common Stock Total Equity39.3 K46 K35.3 K
Very volatile
Common Stock Shares Outstanding44 M41.9 M17.7 M
Slightly volatile
Liabilities And Stockholders Equity114.4 M151.7 M81.6 M
Slightly volatile
Other Current Assets7.9 M7.5 M2.7 M
Slightly volatile
Other Stockholder Equity544.1 M518.2 M254.3 M
Slightly volatile
Total Liabilities24.9 M14.2 M11.3 M
Pretty Stable
Property Plant And Equipment Gross25.3 M24.1 M6.3 M
Slightly volatile
Total Current Assets110.4 M129.6 M76.7 M
Slightly volatile
Common Stock39.9 K42 K95.4 M
Slightly volatile
Other Current Liabilities3.8 M3.6 M1.5 M
Slightly volatile
Current Deferred RevenueM4.2 M4.6 M
Slightly volatile
Short Term Debt177.8 K187.2 K669.7 K
Slightly volatile
Net Tangible Assets274 M261 M93.1 M
Slightly volatile
Capital Surpluse556.9 M530.4 M263.5 M
Slightly volatile
Deferred Long Term Liabilities30 M30.4 M34.3 M
Slightly volatile
Property Plant Equipment27.8 M26.4 M6.6 M
Slightly volatile
Net Invested Capital119.8 M137.5 M63.4 M
Slightly volatile
Net Working Capital109.2 M115.4 M58 M
Slightly volatile
Capital Stock36.3 K48.3 K25.1 K
Slightly volatile
Short and Long Term Debt Total208.4 K159.8 K129.1 K
Slightly volatile
Non Current Liabilities Other166.9 K177.3 K221.3 K
Slightly volatile
Other Liabilities215.1 K226.6 K197.8 K
Slightly volatile
Intangible Assets167.2 K176 K924.3 K
Slightly volatile

Cassava Sciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.6 M1.5 M482.4 K
Slightly volatile
Other Operating Expenses111.3 M106 M29.8 M
Slightly volatile
Research Development93.9 M89.4 M22.7 M
Slightly volatile
Total Operating Expenses111.3 M106 M29.9 M
Slightly volatile
Total Other Income Expense Net9.2 M8.7 M1.7 M
Slightly volatile
Selling General Administrative17.4 M16.5 M7.4 M
Slightly volatile
Non Operating Income Net Other456.4 K434.7 K334 K
Pretty Stable
Interest Income8.2 M7.8 M1.3 M
Slightly volatile
Net Interest Income8.2 M7.8 M1.3 M
Slightly volatile
Reconciled Depreciation1.6 M1.5 M377.6 K
Slightly volatile
Selling And Marketing Expenses1.2 M1.4 M1.5 M
Slightly volatile

Cassava Sciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow211.1 M201 M70.6 M
Slightly volatile
Depreciation1.6 M1.5 M476.4 K
Slightly volatile
End Period Cash Flow69.1 M121.1 M69.4 M
Slightly volatile
Stock Based Compensation3.4 M4.6 M3.2 M
Slightly volatile
Dividends Paid68.6 M77.1 M84 M
Slightly volatile
Change Receivables5.7 M6.4 MM
Slightly volatile
Change To Netincome2.6 M1.9 M3.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.240.270.292
Slightly volatile
PTB Ratio7.216.86624.4819
Very volatile
Days Sales Outstanding145178157
Pretty Stable
Book Value Per Share3.113.27845.0593
Slightly volatile
Average Payables1.8 MM2.2 M
Slightly volatile
Capex To Depreciation0.260.27067.582
Pretty Stable
PB Ratio7.216.86624.4819
Very volatile
Sales General And Administrative To Revenue0.130.140.243
Slightly volatile
Cash Per Share2.742.88896.1398
Slightly volatile
Intangibles To Total Assets0.00110.00120.0036
Slightly volatile
Current Ratio15.749.132323.4293
Very volatile
Tangible Book Value Per Share3.113.27425.0562
Slightly volatile
Receivables Turnover1.622.132.1402
Pretty Stable
Graham Number12.4213.077314.6623
Slightly volatile
Shareholders Equity Per Share3.113.27845.0593
Slightly volatile
Debt To Equity7.0E-47.0E-40.0031
Slightly volatile
Capex Per Share0.00940.00990.0926
Slightly volatile
Graham Net Net2.442.56754.9059
Slightly volatile
Interest Debt Per Share0.00710.0040.0056
Pretty Stable
Debt To Assets6.0E-47.0E-40.0029
Slightly volatile
Price Book Value Ratio7.216.86624.4819
Very volatile
Ebt Per Ebit0.960.91750.953
Pretty Stable
Company Equity Multiplier1.721.10331.3937
Slightly volatile
Long Term Debt To Capitalization2.0E-42.0E-40.0019
Slightly volatile
Total Debt To Capitalization7.0E-47.0E-40.0031
Slightly volatile
Debt Equity Ratio7.0E-47.0E-40.0031
Slightly volatile
Quick Ratio15.749.132323.4293
Very volatile
Net Income Per E B T1.021.090.9649
Very volatile
Cash Ratio13.558.533722.8006
Very volatile
Days Of Sales Outstanding145178157
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.831.0051.0959
Pretty Stable
Price To Book Ratio7.216.86624.4819
Very volatile
Debt Ratio6.0E-47.0E-40.0029
Slightly volatile
Gross Profit Margin684651524
Slightly volatile
Price Fair Value7.216.86624.4819
Very volatile

Cassava Sciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap892 M849.5 M538.9 M
Slightly volatile
Enterprise Value777.5 M740.5 M458.9 M
Slightly volatile

Cassava Fundamental Market Drivers

Forward Price Earnings151.5152
Cash And Short Term Investments121.1 M

Cassava Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Cassava Sciences Financial Statements

Cassava Sciences stakeholders use historical fundamental indicators, such as Cassava Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cassava Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cassava Sciences' assets and liabilities are reflected in the revenues and expenses on Cassava Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cassava Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue4.2 MM
Cost Of Revenue89.4 M93.9 M
Stock Based Compensation To Revenue-1.3 K-1.3 K
Sales General And Administrative To Revenue 0.14  0.13 
Research And Ddevelopement To Revenue-43.5 K-41.3 K
Capex To Revenue-1.7 K-1.6 K
Ebit Per Revenue40 K42 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:
Check out the analysis of Cassava Sciences Correlation against competitors.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.38)
Return On Assets
(0.46)
Return On Equity
(0.11)
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.